Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19,586Revenue $M1,032Net Margin (%)-54.1Altman Z-Score6.0
Enterprise Value $M19,542EPS $-2.7Operating Margin %-45.4Piotroski F-Score5
P/E(ttm)--Beneish M-Score1.7Pre-tax Margin (%)-54.2Higher ROA y-yY
Price/Book17.910-y EBITDA Growth Rate %--Quick Ratio3.5Cash flow > EarningsY
Price/Sales25.25-y EBITDA Growth Rate %--Current Ratio3.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-23.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-56.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M246ROIC % (ttm)-83.2Gross Margin Increase y-yY

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXVanguard Health Care Fund 2015-12-31 Add0.1%$109.03 - $133.26
($121.16)
$ 79.71-34%Add 4.34%9,827,411
VRTXKen Fisher 2015-12-31 Add$109.03 - $133.26
($120.93)
$ 79.71-34%Add 12.48%5,543
VRTXVanguard Health Care Fund 2015-09-30 Reduce-0.03%$98.5 - $141.48
($128.47)
$ 79.71-38%Reduce -1.21%9,418,411
VRTXKen Fisher 2015-09-30 Add$98.5 - $141.48
($128.47)
$ 79.71-38%Add 12.56%4,928
VRTXGeorge Soros 2015-06-30 Sold Out -0.07%$116.43 - $135.82
($125.88)
$ 79.71-37%Sold Out0
VRTXKen Fisher 2015-06-30 Reduce$116.43 - $135.82
($125.88)
$ 79.71-37%Reduce -0.18%4,378
VRTXVanguard Health Care Fund 2015-03-31 Reduce-0.08%$107.88 - $134.25
($119.81)
$ 79.71-33%Reduce -2.80%9,533,911
VRTXGeorge Soros 2015-03-31 Buy 0.07%$107.88 - $134.25
($119.81)
$ 79.71-33%New holding56,912
VRTXKen Fisher 2015-03-31 Add$107.88 - $134.25
($119.81)
$ 79.71-33%Add 0.18%4,386
VRTXVanguard Health Care Fund 2014-12-31 Reduce-0.58%$101.1 - $120.78
($112.61)
$ 79.71-29%Reduce -16.93%9,808,860
VRTXKen Fisher 2014-09-30 Reduce$84.74 - $113.9
($94.97)
$ 79.71-16%Reduce -31.99%4,593
VRTXVanguard Health Care Fund 2014-06-30 Add0.04%$62.44 - $94.68
($70.13)
$ 79.7114%Add 1.54%11,807,500
VRTXGeorge Soros 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 79.7114%Sold Out0
VRTXKen Fisher 2014-06-30 Buy $62.44 - $93.77
($69.73)
$ 79.7114%New holding6,753
VRTXVanguard Health Care Fund 2014-03-31 Add0.13%$67.8 - $85.48
($79.08)
$ 79.711%Add 5.89%11,628,500
VRTXGeorge Soros 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 79.711%New holding10,000
VRTXVanguard Health Care Fund 2013-12-31 Add0.88%$60.18 - $77.83
($69.45)
$ 79.7115%Add 54.06%10,981,500
VRTXVanguard Health Care Fund 2013-09-30 Add0.29%$74.53 - $88.51
($79.62)
$ 79.710%Add 19.00%7,127,997
VRTXVanguard Health Care Fund 2013-06-30 Add1.05%$52.6 - $85.6
($73.64)
$ 79.718%Add 140.58%5,990,000
VRTXNWQ Managers 2013-06-30 Sold Out -0.09%$52.6 - $85.6
($73.64)
$ 79.718%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SMITH IAN FEVP & CFO 2016-02-03Sell12,084$90.84-10.03view
Silva Paul MSVP & Corp Controller 2016-02-03Sell5,062$90.82-10.01view
Sachdev AmitEVP, Policy, Access & Value 2016-02-03Sell10,166$90.84-10.03view
LEIDEN JEFFREY MCEO & President 2016-02-03Sell9,834$90.82-10.01view
Arbuckle Stuart AEVP\Chief Commercial Officer 2016-02-03Sell6,042$90.82-10.01view
BOGER JOSHUA SDirector 2016-02-03Sell5,130$90.81-10view
Chodakewitz JeffreyEVP GMDA, CMO 2016-02-02Sell2,375$91.38-10.56view
BOGER JOSHUA SDirector 2016-01-27Sell11,200$93.22-12.33view
BOGER JOSHUA SDirector 2016-01-20Sell10,400$93.69-12.77view
BOGER JOSHUA SDirector 2016-01-13Sell10,400$98.41-16.95view

Quarterly/Annual Reports about VRTX:

    News about VRTX:

    Articles On GuruFocus.com
    Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter May 20 2015 
    Analysts Confident That Vertex Pharmaceuticals' CF Drug Will Receive FDA Approval May 13 2015 
    Fate Of Cystic Fibrosis Drug By Vertex Is Now Dependent On FDA Approval May 13 2015 
    J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
    William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
    Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex Pharmaceutica Nov 09 2014 
    Weekly CFO Sells Highllight: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc. Oct 05 2014 
    Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
    Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC Dec 16 2012 
    WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 

    More From Other Websites
    Mayor Walsh says he's not going to steal biotechs from Cambridge. Here's why. Feb 09 2016
    [$$] Miner rally subsides as FTSE hits 2012 low Feb 09 2016
    Vertex to Present at Upcoming Investor Conferences Feb 09 2016
    15 big companies face a darkening year Feb 09 2016
    Vertex (VRTX) Down on CRL for Kalydeco Label Expansion Feb 08 2016
    Here's Why Shares Of Vertex Pharmaceuticals Tumbled Feb 05 2016
    Biotech stocks too risky? Feb 05 2016
    Vertex Filing For Expanded Kalydeco Label Rejected By FDA Feb 05 2016
    Vertex Receives Complete Response Letter from U.S. FDA for Use of KALYDECO® (ivacaftor) in People... Feb 05 2016
    How Much Does Biogen Spend on Research and Development? Feb 03 2016
    The Real Risks of Gilead’s Stock Feb 03 2016
    Headline Risk Is Poison for Pharma and Biotech Feb 03 2016
    Street Talk: VRTX, GPRO, TSLA, PGTI Feb 01 2016
    Top Analyst Upgrades and Downgrades: Chipotle, Cisco, Micron, Seagate, Vertex, Disney, Xerox and... Feb 01 2016
    Pre-Market Pulse on Biotechnology Stocks -- ZIOPHARM Oncology, BioMarin Pharma, PTC Therapeutics,... Feb 01 2016
    Vertex Pharma upgraded by Jefferies Feb 01 2016
    Biotech String: Assessing the January Damage, Gilead's Bottoming P/E, Sarepta Panel Date? Feb 01 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK